BioAdvance

Funding rounds backed by BioAdvance.

Export CSV
Funding disclosed in full
$97M
Median round
$97M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Latus Bio, Inc.

Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2

$97MSeries ABiotechUnited States
9 participants8VCBenjamin Franklin Technology PartnersBioAdvanceDCVC BioGaingelsHatch BioFundHelen's Pink Sky FoundationKorea Development BankModi Ventures